Insulin Parenteral and Lorcaserin Extended-Release Tablets
Determining the interaction of Insulin Parenteral and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: Insulin (Parenteral)
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Parenteral-Lorcaserin Hydrochloride
- Insulin Parenteral-Lorcaserin Tablets
- Insulin Parenteral-Lorcet
- Insulin Parenteral-Lorcet Plus
- Insulin Parenteral-Lorcet Tablets
- Insulin Parenteral-Lorlatinib
- Lorcaserin Extended-Release Tablets-Insulin regular
- Lorcaserin Extended-Release Tablets-Insulin Regular (U-100) Cartridges & Prefilled Syringes
- Lorcaserin Extended-Release Tablets-Insulin Regular (U-100) Vials
- Lorcaserin Extended-Release Tablets-Insulin Regular (U-500) Prefilled Pens
- Lorcaserin Extended-Release Tablets-Insulin Regular (U-500) Vials
- Lorcaserin Extended-Release Tablets-Insulin Regular IV Infusion